Marina Richardson, PhD, MSc

Senior Health Economist

Marina joined ICER in August of 2021 as a Health Economist. She was promoted to Senior Health Economist in January of 2023. Prior to coming to ICER, Marina spent 7 years at CADTH (the Canadian Agency for Drugs and Technologies in Health) where she contributed to over 30 drug reimbursement review reports and recommendations. Marina has a well-rounded appreciation for health technology assessment (HTA) having been involved in appraising clinical evidence, economic evidence, and contributing to HTA-related process development for biosimilars and deliberative processes.

Marina completed an MSc in Epidemiology and Biostatistics at Western University, and a PhD in Health Services Research, HTA stream at the University of Toronto in Canada. In her spare time, Marina enjoys connecting with family, friends, and colleagues, playing sports, spending time at the cottage, and traveling.